Trial Details

COMPLETED
Basic Information
Clinical ID c433
Identifier NCT02092285
Trial Title Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Golimumab
Participant Information
Sponsor Merck Sharp & Dohme LLC
City Hoddesdon
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2014-05-09
Primary Completion Date 2016-05-25
Completion Date 2016-05-25